Number of Clinical Trials 2018
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 β
Where does your country rank? Pick it to see its position.
Related Health statistics
More βInteractive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #141
Sierra Leone
- #140
Samoa
- #139
Myanmar
- #138
Mongolia
- #137
Republic of Moldova
- #136
Martinique
- #135
Malta
- #134
Madagascar
- #133
Liberia
- #132
Lesotho
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Bosnia and Herzegovina
In 2018, Bosnia and Herzegovina ranked #103 globally with a total of 2 clinical trials. This figure is notably low compared to many neighboring countries, indicating a limited capacity for clinical research in the region. Contributing factors include a relatively underdeveloped healthcare infrastructure and challenges in attracting foreign investment in medical research.
Barbados
In 2018, Barbados ranked #118 globally with a total of 1 clinical trial. This figure is notably low compared to more active regions in clinical research, reflecting a significant gap in research activity. The limited number of clinical trials in Barbados can be attributed to its small population, which restricts the pool of participants, and a relatively underdeveloped healthcare research infrastructure.
Finland
In 2018, Finland ranked #32 globally with a total of 72 clinical trials. This figure is notable compared to the global average, reflecting Finland's robust healthcare system and commitment to research and development. The country's strong academic institutions and supportive regulatory environment foster innovation, making it an attractive location for clinical research.
Denmark
In 2018, Denmark ranked #12 globally with a total of 313 clinical trials. This figure is significantly higher than the global average, reflecting Denmark's robust healthcare system and supportive regulatory environment for medical research. The country's strong emphasis on innovation and collaboration between universities and the pharmaceutical industry drives its high number of clinical trials.
Costa Rica
Costa Rica ranked #123 globally with a total of 1 clinical trial in 2018. This figure is significantly lower than many of its regional neighbors, reflecting a trend seen in smaller Central American countries. Factors contributing to this low number include the country's limited investment in research and development, as well as a smaller population that may not attract major pharmaceutical companies to conduct clinical trials.
China
In 2018, China ranked #5 globally with 685 clinical trials, positioning it among the leading countries in medical research. This number is significant compared to the global average, reflecting China's robust investment in healthcare and pharmaceuticals. Key drivers include a large and diverse population that facilitates varied clinical research, along with government policies aimed at accelerating drug development and regulatory approvals.
Chad
In 2018, Chad ranked #105 globally with a total of 2 clinical trials. This figure is significantly lower than many neighboring countries, reflecting a challenging healthcare infrastructure compared to regional averages. Limited investment in healthcare and ongoing political instability have hindered the growth of clinical research in the country, impacting access to new treatments and medical advancements.
Ukraine
In 2018, Ukraine ranked #59 globally with a total of 16 clinical trials. This figure is notably lower than many of its Eastern European neighbors, indicating a need for improvement in clinical research infrastructure. The relatively low number of trials can be attributed to ongoing economic challenges and a need for stronger regulatory frameworks that support clinical research initiatives.
Afghanistan
In 2018, Afghanistan ranked #90 globally with a total of 3 clinical trials. This figure is notably low compared to regional neighbors, where countries like Iran and Pakistan conduct significantly more trials, reflecting a broader trend of limited clinical research in the region. The sparse number of clinical trials in Afghanistan can be attributed to ongoing conflict, inadequate healthcare infrastructure, and a lack of investment in research and development.
Cameroon
In 2018, Cameroon ranked #93 globally with a total of 3 clinical trials. This number is significantly lower than the global average, reflecting challenges in research funding and infrastructure compared to countries with higher rankings, such as the United States, which leads in clinical research. The limited number of clinical trials in Cameroon can be attributed to factors such as a lack of investment in healthcare research and the need for improved regulatory frameworks to attract international partnerships.
Analysis & Context
In 2018, the United States led the world with the highest Number of Clinical Trials, recording 6,285 trials, while the global range spanned from just 1 to 6,285 across 141 countries. The average number of clinical trials conducted worldwide was 119.17, with a median of 8, highlighting substantial disparities in medical research activity.
Concentration of Clinical Trials in Developed Economies
The concentration of clinical trials in developed countries is a notable pattern, with the United States, France (1,072), and the United Kingdom (761) among the top contributors. This concentration can be attributed to several factors, including robust healthcare infrastructure, significant investment in medical research, and a regulatory environment conducive to clinical trials. In the United States, the substantial number of trials reflects its leading position in biopharmaceutical innovation and a well-established network of research institutions.
European countries like France and the United Kingdom also benefit from strong governmental support and collaboration between public and private sectors, which facilitate a high volume of clinical trials. These countries have long histories of medical research and development, which continue to drive their prominence in global clinical trial statistics.
Emerging Markets and Increasing Clinical Trial Activity
Emerging markets are showing a notable increase in clinical trial activities, with countries like China (685) and Turkey (534) making significant contributions. The dramatic rise in Turkeyβs clinical trials, with an increase of 247 trials (86.1% growth), reflects its growing investment in healthcare research and an expanding pharmaceutical sector. Similarly, China saw a rise of 142 trials (26.2%), driven by its strategic focus on becoming a global leader in biotech innovation and its vast patient pool, which is attractive for diverse clinical studies.
These increases indicate a shift where emerging economies are not only participants but also leaders in global clinical research. This trend is bolstered by governmental policies aimed at encouraging local and international investment in healthcare research and development.
Minimal Clinical Trial Activity in Developing Countries
At the other end of the spectrum, several developing countries like Samoa, Congo, and Trinidad and Tobago reported only 1 clinical trial each. This minimal activity can be attributed to limited healthcare infrastructure, insufficient funding for research, and regulatory challenges that hinder the establishment and conduct of clinical trials.
The lack of trials in these regions underscores a gap in access to cutting-edge medical research and innovation, which could otherwise contribute to improved health outcomes. Addressing these disparities requires international collaboration, capacity-building initiatives, and investment in local healthcare systems.
Year-over-Year Changes and Regional Dynamics
The data reveals significant year-over-year changes, with the United States adding 434 trials, marking a 7.4% increase. This growth is indicative of the country's continuous expansion in medical research capabilities and the high demand for new therapeutic interventions. In contrast, the Netherlands experienced a reduction of 33 trials, a 13.1% decrease, which may reflect shifting research priorities or challenges in clinical trial recruitment and completion.
Increases in countries like Egypt, which saw an 89.4% rise with 194 additional trials, suggest an expanding research environment and growing interest in regional healthcare advancements. However, countries like Iran saw a decrease of 9 trials, possibly due to geopolitical factors affecting research collaboration and funding.
This analysis highlights the critical role of clinical trials in advancing medical research and the varying capacities and challenges faced by countries worldwide. Understanding these dynamics can inform strategies to enhance global healthcare innovation and ensure equitable access to research advancements.
Frequently Asked Questions About Number of Clinical Trials in 2018
Which country conducted the most clinical trials in 2018?
The United States conducted the most clinical trials in 2018 with a total of 6,285 trials.
What is the average number of clinical trials conducted per country in 2018?
The average number of clinical trials conducted per country in 2018 was 119.
Which country conducted the fewest clinical trials in 2018?
Samoa conducted the fewest clinical trials in 2018, with only 1 trial.
What was the median number of clinical trials conducted by countries in 2018?
The median number of clinical trials conducted by countries in 2018 was 8.
Which countries are in the top 3 for the number of clinical trials conducted in 2018?
The top 3 countries for the number of clinical trials conducted in 2018 were the United States with 6,285 trials, France with 1,072 trials, and the United Kingdom with 761 trials.
How many countries conducted only 1 clinical trial in 2018?
There were 10 countries that conducted only 1 clinical trial in 2018.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2018. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2018
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
βΊEmbed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.